Delivery Order SPE2DB20D2014-SPE2DB24FA98F
Award Date 2/2/24
Potential Completion Date 2/5/24
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Repaglinide 1 mg tablets, a medication used to manage diabetes, with a ceiling value of $13,095.99 and a period of performance through May 6, 2024. The contract was awarded as a Firm Fixed Price Delivery Order and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Repaglinide 1 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $7,964.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 1, 2024 and is not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds significant Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of repaglinide 1 mg tablets. The $2,763.86 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
- The federal contract award is for the delivery of 100 tablets of the pharmaceutical drug Repaglinide 1 mg. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $1,609.80 and a period of performance through February 5, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $6,798.50, is for the delivery of 4,563,575,086 units of the pharmaceutical product Repaglinide 1 mg Tablet in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of February 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
- This federal contract award, with ID SPE2DB22D1017 and SPE2DB25FF6GE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,940.04 firm fixed-price delivery order is for 4567378518 - REPAGLINIDE 2 MG TABLET 100S, and has a completion date of February 26, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, identified as SPE2DB24D1034|SPE2DB25FWAQ2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567321287 units of 1 mg Repaglinide tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,628.82 and a period of performance through February 21, 2025. This award...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Repaglinide 1 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,911.34 with firm fixed pricing and an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Repaglinide 1 mg tablets in a 90-count package at a firm fixed price of $1,189.32. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child contract under its larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,189.32 to AmerisourceBergen Drug Corp for the supply of Repaglinide 1 mg tablets (90-count units) under a firm fixed price contract. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement with no small...